12 Health Care Stocks Moving In Monday's After-Market Session

Gainers

• Aesthetic Medical Intl (NASDAQ:AIH) shares moved upwards by 23.3% to $0.57 during Monday's after-market session. The market value of their outstanding shares is at $27.0 million.
• Harrow (NASDAQ:HROW) shares rose 13.5% to $13.7. The market value of their outstanding shares is at $484.7 million. As per the press release, Q1 earnings came out today.
• Vaxart (NASDAQ:VXRT) stock moved upwards by 12.19% to $0.92. The market value of their outstanding shares is at $162.6 million. The company's, Q1 earnings came out today.
• Modular Medical (NASDAQ:MODD) shares moved upwards by 7.77% to $1.94. The market value of their outstanding shares is at $60.1 million.
• Gossamer Bio (NASDAQ:GOSS) stock moved upwards by 6.94% to $0.77. The market value of their outstanding shares is at $174.1 million. As per the press release, Q1 earnings came out 4 days ago.
• Lantern Pharma (NASDAQ:LTRN) stock moved upwards by 6.43% to $6.48. The company's market cap stands at $69.7 million. As per the news, the Q1 earnings report came out 2 days ago.

Losers

• Augmedix (NASDAQ:AUGX) shares fell 33.8% to $1.55 during Monday's after-market session. The company's market cap stands at $75.8 million. The company's, Q1 earnings came out today.
• Akoya Biosciences (NASDAQ:AKYA) stock decreased by 19.91% to $3.3. The market value of their outstanding shares is at $162.9 million. As per the press release, Q1 earnings came out today.
• Calidi Biotherapeutics (AMEX:CLDI) shares fell 5.0% to $0.21. The market value of their outstanding shares is at $10.3 million.
• Elevation Oncology (NASDAQ:ELEV) stock declined by 4.81% to $3.37. The company's market cap stands at $184.1 million.
• Rockwell Medical (NASDAQ:RMTI) stock decreased by 4.71% to $1.62. The company's market cap stands at $47.5 million.
• Inotiv (NASDAQ:NOTV) stock declined by 4.08% to $4.0. The market value of their outstanding shares is at $103.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.